131
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Intra-Abdominal Abscess and Bacteremia Due to Stenotrophomonas maltophilia After Total Gastrectomy: A Case Report and Literature Review

ORCID Icon, ORCID Icon, , , , & show all
Pages 7197-7204 | Received 30 Aug 2023, Accepted 04 Nov 2023, Published online: 09 Nov 2023

References

  • Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41. doi:10.1128/CMR.00019-11
  • Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol. 1993;43(3):606–609. doi:10.1099/00207713-43-3-606
  • Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev. 1998;11(1):57–80. doi:10.1128/CMR.11.1.57
  • Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893. doi:10.3389/fmicb.2015.00893
  • Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001). Int J Antimicrob Agents. 2003;22(6):551–556. doi:10.1016/S0924-8579(03)00245-0
  • Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101–108. doi:10.1016/j.jhin.2008.05.020
  • Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34(12):1653–1656. doi:10.1086/340707
  • Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004;37(6):359–365.
  • Hashimoto T, Komiya K, Fujita N, et al. Risk factors for 30-day mortality among patients with Stenotrophomonas maltophilia bacteraemia. Infect Dis. 2020;52(6):440–442. doi:10.1080/23744235.2020.1734653
  • Majumdar R, Karthikeyan H, Senthilnathan V, Sugumar S. Review on Stenotrophomonas maltophilia: an emerging multidrug-resistant opportunistic pathogen. Recent Pat Biotechnol. 2022;16(4):329–354.
  • Osawa K, Shigemura K, Kitagawa K, Tokimatsu I, Fujisawa M. Risk factors for death from Stenotrophomonas maltophilia bacteremia. J Infect Chemother. 2018;24(8):632–636. doi:10.1016/j.jiac.2018.03.011
  • Sawai T, Yoshioka S, Matsuo N, Suyama N, Mukae H. Intraabdominal abscess caused by Stenotrophomonas maltophilia: a case report. Int J Surg Case Rep. 2017;41:212–214. doi:10.1016/j.ijscr.2017.10.027
  • Lim DR, Kuk JC, Kim T, Shin EJ. Unusual case of rapid growing intraabdominal abscess caused by Stenotrophomonas maltophilia after laparoscopic appendectomy due to perforated appendicitis: a case report. Medicine. 2017;96(20):e6913. doi:10.1097/MD.0000000000006913
  • Hamza WS, Salama MF, Morsi SS, Abdo NM, Al-Fadhli MA. Benchmarking for surgical site infections among gastrointestinal surgeries and related risk factors: multicenter study in Kuwait. Infect Drug Resist. 2018;11:1373–1381. doi:10.2147/IDR.S167213
  • Agha RA, Fowler AJ, Saetta A, Barai I, Rajmohan S, Orgill DP; SCARE Steering Group. A protocol for the development of reporting criteria for surgical case reports: the SCARE statement. Int J Surg. 2016;27:187–189. doi:10.1016/j.ijsu.2016.01.094
  • Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009;9(5):312–323. doi:10.1016/S1473-3099(09)70083-0
  • Ebara H, Hagiya H, Haruki Y, Kondo E, Otsuka F. Clinical characteristics of Stenotrophomonas maltophilia bacteremia: a regional report and a review of a Japanese case series. Intern Med. 2017;56(2):137–142. doi:10.2169/internalmedicine.56.6141
  • Sumida K, Chong Y, Miyake N, et al. Risk factors associated with Stenotrophomonas maltophilia bacteremia: a matched case-control study. PLoS One. 2015;10(7):e0133731. doi:10.1371/journal.pone.0133731
  • Hotta G, Matsumura Y, Kato K, et al. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS One. 2014;9(11):e112208. doi:10.1371/journal.pone.0112208
  • Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother. 2008;62(5):889–894. doi:10.1093/jac/dkn301
  • Grupo Andaluz para el Estudio de las Enfermedades Infecciosas, Del Toro MD, Rodríguez-Bano J, Herrero M, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine. 2002;81(3):228–239. doi:10.1097/00005792-200205000-00006
  • Tzanetou K, Triantaphillis G, Tsoutsos D, et al. Stenotrophomonas maltophilia peritonitis in CAPD patients: susceptibility to antibiotics and treatment outcome: a report of five cases. Perit Dial Int. 2004;24(4):401–404. doi:10.1177/089686080402400418
  • Baek JE, Jung EY, Kim HJ, et al. Stenotrophomonas maltophilia infection in patients receiving continuous ambulatory peritoneal dialysis. Korean J Intern Med. 2004;19(2):104–108. doi:10.3904/kjim.2004.19.2.104
  • Millán-Díaz B, González-Tabarés L, Cobelo-Casas C, López-Vázquez M, Calviño-Varela J. Stenotrophomonas maltophilia: a rare cause of peritonitis in CAPD patients. Nefrologia. 2017;37(6):646–647. doi:10.1016/j.nefro.2017.03.018
  • Rehman A, Ul-Ain Baloch N, Awais M. Severe ovarian hyperstimulation syndrome complicated by Stenotrophomonas maltophilia peritonitis: a case report and literature review. Intern Med. 2015;54(9):1149–1152. doi:10.2169/internalmedicine.54.3564
  • Machuca E, Ortiz AM, Rabagliati R. Stenotrophomonas maltophilia peritonitis in a patient receiving automated peritoneal dialysis. Adv Perit Dial. 2005;21:63–65.
  • Walsh TR, MacGowan AP, Bennett PM. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 1997;41(7):1460–1464. doi:10.1128/AAC.41.7.1460
  • Alonso A, Martínez JL. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2000;44(11):3079–3086. doi:10.1128/AAC.44.11.3079-3086.2000
  • Kullar R, Wenzler E, Alexander J, Goldstein EJC. Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach. Open Forum Infect Dis. 2022;9(5):ofac095. doi:10.1093/ofid/ofac095
  • Cai B, Tillotson G, Benjumea D, Callahan P, Echols R. The burden of bloodstream infections due to Stenotrophomonas maltophilia in the United States: a large, retrospective database study. Open Forum Infect Dis. 2020;7(5):ofaa141. doi:10.1093/ofid/ofaa141
  • Cho SY, Kang CI, Kim J, et al. Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother. 2014;58(1):581–583. doi:10.1128/AAC.01682-13
  • Apisarnthanarak A, Fraser VJ, Dunne WM, et al. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea. Clin Infect Dis. 2003;37(8):1131–1135. doi:10.1086/378297
  • Hedrick TL, Sawyer RG, Friel CM, Stukenborg GJ. A method for estimating the risk of surgical site infection in patients with abdominal colorectal procedures. Dis Colon Rectum. 2013;56(5):627–637. doi:10.1097/DCR.0b013e318279a93e
  • Bratzler DW, Dellinger EP, Olsen KM, et al. American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA). Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73–156. doi:10.1089/sur.2013.9999
  • Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605–627. doi:10.1086/676022
  • Inokuchi M, Sugita H, Otsuki S, Sato Y, Nakagawa M, Kojima K. Laparoscopic distal gastrectomy reduced surgical site infection as compared with open distal gastrectomy for gastric cancer in a meta-analysis of both randomized controlled and case-controlled studies. Int J Surg. 2015;15:61–67. doi:10.1016/j.ijsu.2015.01.030
  • Kosuga T, Ichikawa D, Komatsu S, et al. Clinical and surgical factors associated with organ/space surgical site infection after laparoscopic gastrectomy for gastric cancer. Surg Endosc. 2017;31(4):1667–1674. doi:10.1007/s00464-016-5156-7
  • Takesue Y, Kusachi S, Mikamo H, et al. Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan. J Infect Chemother. 2018;24(5):330–340. doi:10.1016/j.jiac.2018.02.011
  • Li Z, Li H, Lv P, et al. Prospective multicenter study on the incidence of surgical site infection after emergency abdominal surgery in China. Sci Rep. 2021;11(1):7794. doi:10.1038/s41598-021-87392-8
  • Xiao H, Xiao Y, Quan H, Liu W, Pan S, Ouyang Y. Intra-abdominal infection after radical gastrectomy for gastric cancer: incidence, pathogens, risk factors and outcomes. Int J Surg. 2017;48:195–200. doi:10.1016/j.ijsu.2017.07.081
  • Ince N, Yekenkurul D, Danış A, Çalışkan E, Akkaş İ. An evaluation of six-year Stenotrophomonas maltophilia infections in a university hospital. Afr Health Sci. 2020;20(3):1118–1123. doi:10.4314/ahs.v20i3.13
  • Ban KA, Minei JP, Laronga C, et al. American college of surgeons and surgical infection society: surgical site infection guidelines, 2016 update. J Am Coll Surg. 2017;224(1):59–74. doi:10.1016/j.jamcollsurg.2016.10.029
  • Garrison MW, Anderson DE, Campbell DM, et al. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother. 1996;40(12):2859–2864. doi:10.1128/AAC.40.12.2859